Series A · Healthtech
ReEmerge raises $37M Series A for brain-injury therapy
Cognitive Network Restoration Therapy focuses on viable pathways in the central thalamus.
A restorative approach to cognitive impairment
ReEmerge’s therapy is designed to stimulate underactive but viable circuits disrupted by brain injury, with the aim of restoring function across connected brain networks. The company is advancing the approach through development as an alternative therapeutic direction to rehabilitation alone; its clinical benefit remains to be established through further study.
Use of funds
Expand operations and development
Funding history
Series A · This round$37M